Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Prostaglandin E EP4 receptor (PTGER4) is a G protein-coupled receptor that binds prostaglandin E2 (PGE2), mediating smooth muscle relaxation and playing diverse roles in inflammation, immunity, and vascular biology. It is implicated in various diseases, including asthma, migraine, pain, transplant rejection, and cancer. Selective agonists and antagonists are being explored for therapeutic potential.
Activation of Gαs protein, stimulation of adenylate cyclase, increase in intracellular cAMP, activation of protein kinase A (PKA), phosphorylation of CREB, activation of PI3K/AKT/mTOR and MAPKs such as ERK and p38
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E EP4 Receptor (PTGER4).